Related Experiment Videos
Intracranial hemorrhage and oral anticoagulant treatment
Insights
Long-term oral anticoagulant use increases intracranial hemorrhage (ICH) risk, particularly with excessive anticoagulation or prior cerebral infarct. Careful coagulation monitoring is crucial, especially in the first year, to mitigate ICH risk.
Area of Science:
- Neurology
- Hematology
- Pharmacology
Background:
- Long-term oral anticoagulant therapy is essential for preventing thromboembolic events.
- Intracranial hemorrhage (ICH) is a serious complication of anticoagulant use.
- Identifying specific risk factors for anticoagulant-related ICH is critical for patient safety.
Purpose of the Study:
- To determine risk factors for intracranial hemorrhage (ICH) in patients on long-term oral anticoagulants.
- To identify clinical and radiological features distinguishing anticoagulant-related ICH from spontaneous ICH.
Main Methods:
- Retrospective analysis of three patient groups: anticoagulant-related ICH, spontaneous ICH, and oral anticoagulant users without ICH.
- CT scans and clinical data, including anticoagulation parameters and outcomes, were analyzed.
- Multivariate analysis was used to identify significant risk factors.
Main Results:
- Anticoagulant-related ICH patients had larger supratentorial bleed volumes compared to spontaneous ICH.
- Significant risk factors for ICH included duration of anticoagulation, elevated prothrombin time, excessive anticoagulation, prior cerebral infarct, and acénocoumarol use.
- Age and indication for anticoagulation were not significant risk factors.
Conclusions:
- Anticoagulant-related ICH is clinically similar to spontaneous ICH, with bleeding volume being a key differentiator.
- Frequent and meticulous coagulation monitoring, especially within the first year of therapy, is essential to reduce ICH risk.
Objective:
To detect risk factors for intracranial hemorrhage (ICH) in patients with long-term oral anticoagulant and to identify clinical or radiological data specific of anticoagulant-related ICH.
Methods And Patients:
Three groups of patients were included. Group 1 represents patients who were admitted because of anticoagulant-related ICH between January 1984 and February 1996. All patients underwent CT scan. Clinical data, anticoagulation parameters, location and volume of the ICH, treatment and the 30-days in-hospital mortality were analyzed. Group 2 consisted of patients selected at random among all patients with spontaneous ICH admitted to our department during the same period of time. Patients without ICH, but regularly taking oral anticoagulants constituted group 3.
Results:
Seventy-nine patients with anticoagulant-related ICH were compared to 127 patients with spontaneous ICH. The volume of supratentorial ICH was greater in group 1 of patients and was correlated with a worse prognosis. Comparison of group 1 with group 3 (212 controls) demonstrated that length of anticoagulation, prothrombin time or excessive anticoagulation, prior cerebral infarct and use of acénocoumarol, but not age or indication of anticoagulant, were significant risk factors for ICH in multivariate analysis.
Conclusions:
The results emphasize that anticoagulant-related ICH are not clinically different from spontaneous ICH except for volume of bleeding, and that frequent and careful coagulation monitoring is needed, especially during the first year in order to decrease the risk of ICH.